α-Tocopherol counteracts ritonavir-induced proinflammatory cytokines expression in differentiated THP-1 cells

BioFactors

Volumn 31, Issue 3-4, 2007, Pages 171-179

  Guo, Weimin ^a   Zingg, Jean Marc ^a   Meydani, Mohsen ^a   Azzi, Angelo ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Inflammatory cytokines; Ritonavir; THP 1 cells; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; CD36 ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEINASE INHIBITOR; RITONAVIR;

ANTIGEN EXPRESSION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL STRAIN; CELL STRAIN THP 1; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ANTAGONISM; DYSLIPIDEMIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VITAMIN SUPPLEMENTATION;

EID: 57349163211     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520310304     Document Type: Article

References (35)

1. R.W. Alexander, Inflammation and coronary artery disease, N Engl J Med 331 (1994), 468-469.
2. R. Altman, Risk factors in coronary atherosclerosis athero-inflammation: the meeting point, Thromb J 1 (2003), 4.
3. P. Andre, M. Groettrup, P. Klenerman, R. de Giuli, B.L. Booth, Jr., V. Cerundolo, M. Bonneville, F. Jotereau, R.M. Zinkernagel and V. Lotteau, An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses, Proc Natl Acad Sci USA 95 (1998), 13120-13124.
4. J. Auwerx, The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation, Experientia 47 (1991), 22-31.
5. B.M. Bergersen, Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy, Drugs 66 (2006), 1971-1987.
6. E.L. Bradshaw, X.A. Li, T. Guerin, W.V. Everson, M.E. Wilson, A.J. Bruce-Keller, R.N. Greenberg, L. Guo, S.A. Ross and E.J. Smart, Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C, Am J Physiol Cell Physiol 291 (2006), C1271-C1278.
7. J. Dressman, J. Kincer, S.V. Matveev, L. Guo, R.N. Greenberg, T. Guerin, D. Meade, X.A. Li, W. Zhu, A. Uittenbogaard, M.E. Wilson and E.J. Smart, HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages, J Clin Invest 111 (2003), 389-397.
8. S.E. Epstein, Y.F. Zhou and J. Zhu, Infection and atherosclerosis: emerging mechanistic paradigms, Circulation 100 (1999), e20-e28.
9. A. Gerber, A. Heimburg, A. Reisenauer, A. Wille, T. Welte and F. Buhling, Proteasome inhibitors modulate chemokine production in lung epithelial and monocytic cells, Eur Respir J 24 (2004), 40-48.
10. S. Grigem, P. Fischer-Posovszky, K.M. Debatin, E. Loizon, H. Vidal and M. Wabitsch, The effect of the HIV protease inhibitor ritonavir on proliferation, differentiation, lipogenesis, gene expression and apoptosis of human preadipocytes and adipocytes, Horm Metab Res 37 (2005), 602-609.
11. A. Grigorian, R. Hurford, Y. Chao, C. Patrick and T.D. Langford, Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir, BMC Neurosci 9 (2008), 27.
12. W. Guo, M.L. Wise, F.W. Collins and M. Meydani, Avenanthramides, polyphenols from oats, inhibit IL-1beta-induced NF-kappaB activation in endothelial cells, Free Radic Biol Med 44 (2008), 415-429.
13. M.S. Hipp, C. Urbich, P. Mayer, J. Wischhusen, M. Weller, M. Kracht and I. Spyridopoulos, Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1, Eur J Immunol 32 (2002), 2208-2217.
14. S.P. Jones, O. Janneh, D.J. Back and M. Pirmohamed, Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors, Antivir Ther 10 (2005), 207-213.
15. S. Joshi-Barve, S.S. Barve, W. Butt, J. Klein and C.J. McClain, Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes, Hepatology 38 (2003), 1178-1187.
16. R.J. Kim, C.G. Wilson, M. Wabitsch, M.A. Lazar and C.M. Steppan, HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism, Obesity (Silver Spring) 14 (2006), 994-1002.
17. T. Kohro, T. Tanaka, T. Murakami, Y. Wada, H. Aburatani, T. Hamakubo and T. Kodama, A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage, J Atheroscler Thromb 11 (2004), 88-97.
18. C. Lagathu, J.P. Bastard, M. Auclair, M. Maachi, M. Kornprobst, J. Capeau and M. Caron, Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro, Antivir Ther 9 (2004), 911-920.
19. L. Li, E. Messas, E.L. Batista, Jr., R.A. Levine and S. Amar, Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model, Circulation 105 (2002), 861-867.
20. A. Munteanu, J.M. Zingg, E. Ogru, R. Libinaki, R. Gianello, S. West, Y. Negis and A. Azzi, Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation, Biochem Biophys Res Commun 318 (2004), 311-316.
21. A. Munteanu, J.M. Zingg, R. Ricciarelli and A. Azzi, CD36 overexpression in ritonavir-treated THP-1 cells is reversed by alpha-tocopherol, Free Radic Biol Med 38 (2005), 1047-1056.
22. A. Munteanu, R. Ricciarelli, S. Massone and J.M. Zingg, Modulation of proteasome activity by vitamin E in THP-1 monocytes, IUBMB Life 59 (2007), 771-780.
23. K. Nakayama, A. Furusu, Q. Xu, T. Konta and M. Kitamura, Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway, J Immunol 167 (2001), 1145-1150.
24. Y. Negis, M. Meydani, J.M. Zingg and A. Azzi, Molecular mechanism of alpha-tocopheryl-phosphate transport across the cell membrane, Biochem Biophys Res Commun 359 (2007), 348-353.
25. S. Pati, C.B. Pelser, J. Dufraine, J.L. Bryant, M.S. Reitz Jr. and F.F. Weichold, Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma, Blood 99 (2002), 3771-3779.
26. D. Periard, A. Telenti, P. Sudre, J.J. Cheseaux, P. Halfon, M.J. Reymond, S.M. Marcovina, M.P. Glauser, P. Nicod, R. Darioli and V. Mooser, Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study, Circulation 100 (1999), 700-705.
27. P.M. Ridker, Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view, Blood Coagul Fibrinolysis 10(Suppl 1) (1999), S9-S12.
28. R. Ross, Atherosclerosis - an inflammatory disease, N Engl J Med 340 (1999), 115-126.
29. G. Schmidtke, H.G. Holzhutter, M. Bogyo, N. Kairies, M. Groll, R. de Giuli, S. Emch and M. Groettrup, How an inhibitor of the HIV-I protease modulates proteasome activity, J Biol Chem 274 (1999), 35734-35740.
30. S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno and K. Tada, Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int J Cancer 26 (1980), 171-176.
31. S. Tsuchiya, Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno and K. Tada, Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester, Cancer Res 42 (1982), 1530-1536.
32. C. Vernochet, S. Azoulay, D. Duval, R. Guedj, F. Cottrez, H. Vidal, G. Ailhaud and C. Dani, Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines, J Biol Chem 280 (2005), 2238-2243.
33. H.M. Wu, H.C. Wen and W.W. Lin, Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signal-regulating kinase-dependent extracellular signal-related kinase and c-Jun N-terminal kinase activation, Am J Respir Cell Mol Biol 27 (2002), 234-243.
34. H.M. Wu, K.H. Chi and W.W. Lin, Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production, FEBS Lett 526 (2002), 101-105.
35. D. Wu, Z. Ren, M. Pae, W. Guo, X. Cui, A.H. Merrill and S.N. Meydani, Aging up-regulates expression of inflammatory mediators in mouse adipose tissue, J Immunol 179 (2007), 4829-4839.